A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics
Clinical trial NCT01806376 · UNKNOWN
Trial details
- NCT number
- NCT01806376
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.